Evidence map›Paper›PMID 32615971›Full record

ArticleBMC urology2020

Small renal masses in Latin-American population: characteristics and prognostic factors for survival, recurrence and metastasis - a multi-institutional study from LARCG database.

Thiago Camelo Mourão, Diego Abreu, Gustavo F Carvalhal, Guillermo Gueglio, Walter H da Costa, Vinicius Fernando Calsavara, Luis Meza-Montoya, Rubén G Bengió, Carlos Scorticati, Ricardo Castillejos-Molina and 21 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 17 institutions in 6 countries.

Thiago Camelo MourãoA.C. Camargo Cancer Center, Rua Antônio Prudente 211, Liberdade, São Paulo, 01509-010, Brazil. thiagocmourao@gmail.com.ORCID http://orcid.org/0000-0003-4800-6009
Diego AbreuPasteur Hospital, Montevideo, Uruguay.
Gustavo F CarvalhalSão Lucas Hospital - PUCRS, Porto Alegre, Brazil.
Guillermo GueglioItalian Hospital, Buenos Aires, Argentina.
Walter H da CostaA.C. Camargo Cancer Center, Rua Antônio Prudente 211, Liberdade, São Paulo, 01509-010, Brazil.
Vinicius Fernando CalsavaraEpidemiology and Statistics Department, International Research Center, A.C.Camargo Cancer Center, São Paulo, Brazil.
Luis Meza-MontoyaInstituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Rubén G BengióUrological Center Profesor Bengió, Cordoba, Argentina.
Carlos ScorticatiClinics Hospital José de San Martín, Buenos Aires, Argentina.
Ricardo Castillejos-MolinaInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCNSZ), Mexico City, Mexico.
Francisco Rodríguez-CovarrubiasInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCNSZ), Mexico City, Mexico.
Ana María Autran-GómezJiménez Díaz Foundation, Madrid, Spain.
José Gadu Campos-SalcedoMilitary Hospital, Mexico City, Mexico.
Alejandro NolazcoBritish Hospital, Buenos Aires, Argentina.
Carlos AmeriGerman Hospital, Buenos Aires, Argentina.
Hamilton ZampolliInstituto Arnaldo Vieira de Carvalho, São Paulo, Brazil.
Raúl LangenhinCorporación Médica de Paysandú (COMEPA), Paysandu, Uruguay.
Diego MuguruzaCorporación Médica de Paysandú (COMEPA), Paysandu, Uruguay.
Marcos Tobias MachadoInstituto Arnaldo Vieira de Carvalho, São Paulo, Brazil.
Pablo MingotePoliclinico Neuquén, Neuquen, Argentina.
Jorge ClavijoClinics Hospital, Montevideo, Uruguay.
Lucas NogueiraFederal University of Minas Gerais, Belo Horizonte, Brazil.
Omar ClarkMilitary Hospital, Montevideo, Uruguay.
Agustín R RovegnoCentro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina.
Fernando P SecinSan Lázaro Foundation and FUNDES, Buenos Aires, Argentina.
Ricardo DeciaPasteur Hospital, Montevideo, Uruguay.
Gustavo C GuimarãesSurgical Oncology Coordinator at Beneficencia Portuguesa Hospital, São Paulo, Brazil.
Sidney GlinaABC Medical School, São Paulo, Brazil.
Oscar Rodríguez-FabaPuigvert Foundation, Barcelona, Spain.
Joan PalouPuigvert Foundation, Barcelona, Spain.
Stenio C ZequiA.C. Camargo Cancer Center, Rua Antônio Prudente 211, Liberdade, São Paulo, 01509-010, Brazil.
AC Camargo Hospital · BRFaculdade de Medicina do ABC · BRInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXInstitut Pasteur de Montevideo · UYPuigvert Foundation · ESBeneficência Portuguesa de São Paulo · BRCentro de Educación Médica e Investigaciones Clínicas Norberto Quirno · ARFavaloro Foundation · ARHospital Británico de Buenos Aires · ARHospital Central Militar · MXHospital de Clínicas · UYHospital de Clínicas "José de San Martín" · ARHospital Italiano de Buenos Aires · ARHospital São Lucas da PUCRS · BRHospital Universitario Fundación Jiménez Díaz · ESInstituto Nacional de Enfermedades Neoplásicas · PEUniversidade Federal de Minas Gerais · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo evaluate demographic, clinical and pathological characteristics of small renal masses (SRM) (≤ 4 cm) in a Latin-American population provided by LARCG (Latin-American Renal Cancer Group) and analyze predictors of survival, recurrence and metastasis.

methodsA multi-institutional retrospective cohort study of 1523 patients submitted to surgical treatment for non-metastatic SRM from 1979 to 2016. Comparisons between radical (RN) or partial nephrectomy (PN) and young or elderly patients were performed. Kaplan-Meier curves and log-rank tests estimated 10-year overall survival. Predictors of local recurrence or metastasis were analyzed by a multivariable logistic regression model.

resultsPN and RN were performed in 897 (66%) and 461 (34%) patients. A proportional increase of PN cases from 48.5% (1979-2009) to 75% (after 2009) was evidenced. Stratifying by age, elderly patients (≥ 65 years) had better 10-year OS rates when submitted to PN (83.5%), than RN (54.5%), p = 0.044. This disparity was not evidenced in younger patients. On multivariable model, bilaterality, extracapsular extension and ASA (American Society of Anesthesiologists) classification ≥3 were predictors of local recurrence. We did not identify significant predictors for distant metastasis in our series.

conclusionsPN is performed in Latin-America in a similar proportion to developed areas and it has been increasing in the last years. Even in elderly individuals, if good functional status, sufficiently fit to surgery, and favorable tumor characteristics, they should be encouraged to perform PN. Intending to an earlier diagnosis of recurrence or distant metastasis, SRM cases with unfavorable characteristics should have a more rigorous follow-up routine.

Indexed as

AgedCarcinoma, Renal CellCohort StudiesDatabases, FactualFemaleHumansKidney NeoplasmsLatin AmericaMaleMiddle AgedNeoplasm Recurrence, LocalNephrectomyPrognosisRetrospective StudiesSurvival RateKidney cancerLatin AmericaNephrectomyNephron-sparing surgeryRenal cell carcinoma

Identifiers

PMID32615971
PMCPMC7331283
OpenAlexW3038959929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.